• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Research of 2-Chloro-6-hydroxypyridine-3-carboxylic acid (CAS: 38025-90-0)

2-Chloro-6-hydroxypyridine-3-carboxylic acid (CAS: 38025-90-0) is a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Recent studies have highlighted its significance in drug development, particularly in the design of novel antibacterial and anti-inflammatory agents. This research briefing provides an overview of the latest findings related to this compound, focusing on its chemical properties, synthetic routes, and potential applications in the pharmaceutical industry.

A study published in the Journal of Medicinal Chemistry (2023) explored the role of 2-chloro-6-hydroxypyridine-3-carboxylic acid as a building block for the synthesis of new quinolone derivatives. The researchers demonstrated that this compound could be efficiently converted into a series of quinolone analogs with potent antibacterial activity against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus. The study also highlighted the compound's favorable pharmacokinetic properties, making it a promising candidate for further development.

In another recent investigation, scientists from the University of Cambridge reported a novel enzymatic method for the synthesis of 2-chloro-6-hydroxypyridine-3-carboxylic acid. This green chemistry approach utilized a recombinant hydroxynitrile lyase to catalyze the conversion of 2-chloro-6-hydroxypyridine-3-carbonitrile into the corresponding carboxylic acid with high yield and enantioselectivity. The study, published in ACS Catalysis (2024), emphasized the environmental benefits of this method compared to traditional chemical synthesis routes.

Further research has explored the potential of 2-chloro-6-hydroxypyridine-3-carboxylic acid in the development of anti-inflammatory drugs. A team from the National Institutes of Health (NIH) identified this compound as a key intermediate in the synthesis of novel COX-2 inhibitors. Their findings, published in Bioorganic & Medicinal Chemistry Letters (2023), showed that derivatives of this compound exhibited significant anti-inflammatory activity in animal models, with reduced gastrointestinal side effects compared to traditional NSAIDs.

The pharmaceutical industry has shown increasing interest in 2-chloro-6-hydroxypyridine-3-carboxylic acid due to its versatility as a synthetic intermediate. Several patent applications filed in 2023-2024 describe novel processes for its large-scale production and purification. These technological advancements are expected to lower production costs and improve the availability of this important building block for drug discovery programs.

Looking ahead, researchers anticipate that 2-chloro-6-hydroxypyridine-3-carboxylic acid will continue to play a crucial role in medicinal chemistry. Its unique structural features make it particularly valuable for the development of targeted therapies, including kinase inhibitors and GPCR modulators. Ongoing studies are investigating its potential in oncology and neurodegenerative disease research, with preliminary results showing promising activity in relevant biological assays.

• 934639-56-2(2-Chloro-5-fluoro-1,6-dihydro-6-oxo-3-pyridinecarboxylic acid)
• 1807213-43-9(Ethyl 2-chloro-6-hydroxynicotinate)
• 70180-38-0(Ethyl 2-Chloro-4,6-dihydroxynicotinate)
• 6313-51-5(6-Chloro-2-oxo-1,2-dihydropyridine-4-carboxylic acid)
• 869357-64-2(methyl 2-chloro-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxylate)
• 6937-04-8(methyl 2-chloro-6-hydroxypyridine-4-carboxylate)
• 853109-24-7(methyl 2-chloro-1-methyl-6-oxo-pyridine-3-carboxylate)
• 934639-08-4(methyl 2-chloro-5-ethyl-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate)
• 1805670-73-8(Methyl 2-chloro-6-hydroxynicotinate)
• 151143-32-7(2(1H)-Pyridinone, 6-chloro-5-(methoxymethyl)-)